Back to Search Start Over

Association of Insomnia and Obstructive Sleep Apnea with Worse Oral Mucositis and Quality of Life in Head and Neck Cancer Patients Undergoing Radiation Therapy.

Authors :
Iovoli, Austin J.
Smith, Kelsey
Yu, Han
Kluczynski, Melissa A.
Jungquist, Carla R.
Ray, Andrew D.
Farrugia, Mark K.
Gu, Fangyi
Singh, Anurag K.
Source :
Cancers; Apr2024, Vol. 16 Issue 7, p1335, 12p
Publication Year :
2024

Abstract

Simple Summary: Patients with head and neck cancer undergoing curative treatment with radiation therapy and chemotherapy often experience sleep disturbances that can affect pain and quality of life. We prospectively studied this patient population using sleep symptom questionnaires to assess the impact of sleep disturbances on patient-reported outcomes. We found that at baseline, 39% of patients had subthreshold or greater insomnia and 54% screened positive for OSA. Upon completion of radiation therapy, patients with these sleep disturbances had worse patient-reported quality of life and oral mucositis pain. These findings highlight the importance of managing sleep disturbances as a potential method to improve patient-reported outcomes for patients undergoing radiation therapy for head and neck cancer. Background: Patients with head and neck cancer (HNC) undergoing radiation therapy (RT) often experience sleep disturbances that may contribute to oral mucositis (OM) and quality of life (QOL). Methods: Patients with HNC treated with RT at a single institution were examined. Sleep questionnaires were given on the first day of RT to assess for insomnia and obstructive sleep apnea (OSA). Patient-reported QOL and oral mucositis were assessed during RT. Associations between insomnia and OSA with QOL were assessed using the Mann–Whitney U test. Linear mixed models assessed associations with OM. Results: Among 87 patients, 34 patients (39%) had subthreshold or greater insomnia and 47 patients (54%) screened positive for OSA. Upon RT completion, patients with subthreshold or greater insomnia had worse physical function (p = 0.005), fatigue (p = 0.01), insomnia (p < 0.001), and sticky saliva (p = 0.002). Patients screening positive for OSA had worse physical function (p = 0.01), sticky saliva (p = 0.02), fatigue (p = 0.007), insomnia (p = 0.009), and pain (p = 0.005). Upon linear mixed model evaluation, subthreshold or greater insomnia (p = 0.01) and positive OSA screen (p = 0.002) were associated with worse OM. Conclusion: Insomnia and OSA are highly prevalent in patients with HNC undergoing RT. These sleep disturbances are associated with worse QOL and OM during treatment. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20726694
Volume :
16
Issue :
7
Database :
Complementary Index
Journal :
Cancers
Publication Type :
Academic Journal
Accession number :
176597980
Full Text :
https://doi.org/10.3390/cancers16071335